Penumbra, Inc. (NYSE:PEN – Get Free Report) EVP Johanna Roberts sold 600 shares of the stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $214.14, for a total value of $128,484.00. Following the completion of the transaction, the executive vice president now owns 63,037 shares in the company, valued at approximately $13,498,743.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Johanna Roberts also recently made the following trade(s):
- On Monday, October 2nd, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $237.82, for a total value of $142,692.00.
- On Friday, September 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $265.11, for a total transaction of $159,066.00.
Penumbra Price Performance
Shares of NYSE:PEN opened at $223.67 on Friday. The company has a market capitalization of $8.63 billion, a P/E ratio of 217.16 and a beta of 0.58. The company’s 50-day moving average is $224.84 and its 200 day moving average is $274.29. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.41 and a current ratio of 5.99. Penumbra, Inc. has a fifty-two week low of $180.93 and a fifty-two week high of $348.67.
Analysts Set New Price Targets
Institutional Investors Weigh In On Penumbra
Large investors have recently added to or reduced their stakes in the company. FMR LLC increased its stake in shares of Penumbra by 1.3% in the first quarter. FMR LLC now owns 5,619,517 shares of the company’s stock worth $1,566,103,000 after purchasing an additional 72,178 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Penumbra by 2.0% during the third quarter. Vanguard Group Inc. now owns 3,407,434 shares of the company’s stock worth $646,050,000 after acquiring an additional 68,266 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Penumbra by 104.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,185,062 shares of the company’s stock worth $608,956,000 after acquiring an additional 1,115,176 shares during the period. State Street Corp grew its position in shares of Penumbra by 1.5% in the second quarter. State Street Corp now owns 1,061,701 shares of the company’s stock valued at $365,289,000 after purchasing an additional 16,028 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of Penumbra by 6.7% during the 2nd quarter. Geode Capital Management LLC now owns 552,423 shares of the company’s stock valued at $190,067,000 after purchasing an additional 34,618 shares during the period. Hedge funds and other institutional investors own 88.18% of the company’s stock.
Penumbra, Inc, together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands.
- Five stocks we like better than Penumbra
- Stock Market Sectors: What Are They and How Many Are There?
- Williams-Sonoma is a steal for buy-and-hold investors
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- A closer look at Warren Buffett’s latest surprise purchase
- How to Invest in Virtual Reality
- GE stock surges to six-year high: What’s behind the move?
Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.